PPLPHARMA - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.2
Show all parameters (20 more)
🧾 Chart Verdict
Short-term entry zones would be between 208 ₹ - 213 ₹ based on the current price action and resistance levels observed around 232₹. An exit strategy could be triggered at the next support level around 195 ₹, or if the RSI dips below 48 while maintaining a high volume trend. Overall, while the momentum is positive, the elevated valuation warrants careful monitoring for potential reversals.
✅ Positive
The price is currently trading above the 200-day moving average (DMA 200) and exhibiting a period of sustained upward momentum as indicated by the RSI, suggesting potential for further gains. Furthermore, the volume has been consistently high over the past week, reinforcing this upward trend.
⚠️ Limitation
Despite the positive momentum, the elevated P/E ratio of 36.3 compared to the industry average of 34.6 indicates a premium valuation which could present downside risk if growth expectations aren’t met. The recent ‘Sell’ rating from MarketsMOJO adds a layer of caution, and a potential pullback remains possible should sentiment shift negatively.
📉 Company Negative News
MarketsMOJO has issued a “Sell” rating for Piramal Pharma, suggesting investors may want to consider exiting their positions or remain cautious. Business Standard reports an uptick in volumes at Pfizer Ltd., which could be diverting attention away from PPLPHARMA.
📈 Company Positive News
The recent quarterly profit increase of 113 Cr. represents solid performance and demonstrates the company's financial strength, potentially supporting continued price appreciation if maintained. MarketsMojo’s analysis highlighted a CDMO recovery lifting EBITDA, offering a positive sector-specific narrative that could bolster investor confidence.
🏭 Industry
The pharmaceutical sector is currently experiencing recovery driven by increased demand for contract development and manufacturing services (CDMO). Industry PE ratios are relatively high reflecting the growth potential of this segment; however, recent ratings suggest caution within this sector.